PHA First Exam Fall 2003

Similar documents
PHA First Exam. Fall 2004

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam Fall 2006

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Renal Function. 1. Glomerular filtration 2. Active tubular secretion 3. Passive tubular reabsorption 4. Excretion

PHA Final Exam Fall 2001

PHA5128 Dose Optimization II Case Study I Spring 2013

PHA First Exam Fall 2013

General Principles of Pharmacology and Toxicology

PHA Spring First Exam. 8 Aminoglycosides (5 points)

PHA 5128 Spring 2009 First Exam (Version B)

Renal Excretion of Drugs

General Principles of Pharmacology and Toxicology

PHA 5128 Final Exam Spring 2004 Version A. On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Pharmacokinetics in Drug Development. Edward P. Acosta, PharmD Professor & Director Division of Clinical Pharmacology Director, CCC PK/PD Core

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

Basic Concepts in Pharmacokinetics. Leon Aarons Manchester Pharmacy School University of Manchester

Excretion of Drugs. Prof. Hanan Hagar Pharmacology Unit Medical College

BASIC PHARMACOKINETICS

= (6000 ml air / min * 0.04 ml CO 2 / ml air) / 54 ml CO 2 / dl plasma

Renal-Related Questions

BIOL 2402 Renal Function

PHA 4120 Second Exam Key Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

ADME Review. Dr. Joe Ritter Associate Professor of Pharmacology

Functional morphology of kidneys Clearance

Lippincott Questions Pharmacology

Renal Physiology. April, J. Mohan, PhD. Lecturer, Physiology Unit, Faculty of Medical Sciences, U.W.I., St Augustine.

Renal Clearance. Dr. Eman El Eter

Filtration and Reabsorption Amount Filter/d

PHA 5128 Spring 2000 Final Exam

The kidney. (Pseudo) Practical questions. The kidneys are all about keeping the body s homeostasis. for questions Ella

Clearance and Reabsorption. Use the following data to answer these questions. a. plasma flow rate in the afferent arterioles:

Chapter 23. Composition and Properties of Urine

Rational Dose Prediction. Pharmacology. φαρμακον. What does this mean? pharmakon. Medicine Poison Magic Spell

Renal Quiz - June 22, 21001

Name: UFID: PHA Exam 2. Spring 2013

Terminology. Terminology. Terminology. Molarity number of moles of solute / Liter of solution. a) Terminology b) Body Fluid Compartments

PHAR 7632 Chapter 16

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy

Drug elimination and Hepatic clearance Chapter 6

Regulation of fluid and electrolytes balance

Pharmacokinetics of Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

LECTURE 25: FILTRATION AND CLEARANCE NEPHRON FILTRATION

One-Compartment Open Model: Intravenous Bolus Administration:

Glomerular filtration rate (GFR)

The principal functions of the kidneys

Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment

Unit 2b: EXCRETION OF DRUGS. Ms.M.Gayathri Mpharm (PhD) Department of Pharmaceutics Krishna Teja Pharmacy college Subject code: 15R00603 (BPPK)

MAJOR FUNCTIONS OF THE KIDNEY

RENAL SYSTEM 2 TRANSPORT PROPERTIES OF NEPHRON SEGMENTS Emma Jakoi, Ph.D.

Introduction to Clinical Diagnosis Nephrology

KD02 [Mar96] [Feb12] Which has the greatest renal clearance? A. PAH B. Glucose C. Urea D. Water E. Inulin

Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations

Physiology questions review

Metformin Associated Lactic Acidosis. Jun-Ki Park 9/6/11

PRESCRIBING IN LIVER AND RENAL DISEASE

NROSCI/BIOSC 1070 and MSNBIO 2070 Exam # 2 October 25, 2013 Total POINTS: % of grade in class

You should know the T max for any substance that you use and for PAH ; T max = mg / min

Tamer Barakat. Abdul Aziz ALShamali. Abdul Aziz ALShamali

BCH 450 Biochemistry of Specialized Tissues

5/10/2014. Observation, control of blood pressure. Observation, control of blood pressure and risk factors.

Glomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC

Estimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance. BCH472 [Practical] 1

LD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR)

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE

Industrial Toxicology

Renal System Physiology

BLOCK REVIEW Renal Physiology. May 9, 2011 Koeppen & Stanton. EXAM May 12, Tubular Epithelium

UNIVERSITY OF THE WEST INDIES, ST AUGUSTINE

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology

Renal Impairment From Dettli to Guideline: What can we learn?

1. remove: waste products: urea, creatinine, and uric acid foreign chemicals: drugs, water soluble vitamins, and food additives, etc.

Biopharmaceutics. Tips Worth Tweeting. Contributor: Sandra Earle

Scaling Renal Function in Neonates and Infants to Describe the Pharmacodynamics of Antibiotic Nephrotoxicity

(KFTs) IACLD CME, Monday, February 20, Mohammad Reza Bakhtiari, DCLS, PhD

The ADME properties of most drugs strongly depends on the ability of the drug to pass through membranes via simple diffusion.

Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure.

Na + Transport 1 and 2 Linda Costanzo, Ph.D.

MODULE 8: URINALYSIS AND ACID BASE BALANCE

Pharmacokinetics. Karim Rafaat

Human Urogenital System 26-1

Ch 19: The Kidneys. Functional unit of kidneys:?? Developed by John Gallagher, MS, DVM

Renal Reabsorption & Secretion

ICU Volume 11 - Issue 3 - Autumn Series

Effects of Liver Disease on Pharmacokinetics

Kidney Physiology. Mechanisms of Urine Formation TUBULAR SECRETION Eunise A. Foster Shalonda Reed

Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics

TDM. Measurement techniques used to determine cyclosporine level include:

Nephron Function and Urine Formation. Ms. Kula December 1, 2014 Biology 30S

Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University

It the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues.

ENVIRONMENTAL TOXICOLOGY

Renal System and Excretion

BIOPHARMACEUTICS and CLINICAL PHARMACY

Urinary System. consists of the kidneys, ureters, urinary bladder and urethra

Transcription:

PHA 5127 First Exam Fall 2003 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question/Points 1. /14 pts 2. /6 pts 3. /15 pts 4. /12 pts 5. /20 pts 6. /10pts 7. /10pts 8. /12pts 9. /10pts 10. /16pts TOTAL /125 pts 1

1. List the wrong statements. A drug shows a plasma protein binding of 50% and a volume of distribution of 100 L. The intrinsic clearance of this drug in the liver is much smaller than the liver blood flow. The oral bioavailability of this drug: (14 points) A will be 50%. B will highly depend on liver blood flow. C will be very small (< 10%). D will be affected by the GFR. E will be significantly increased if the tissue binding will beis increased. F will be significantly increased if the plasma protein binding is increased. G will be significantly increased if the intrinsic clearance is increased. The wrong statement(s) is (are): 2

2. Compare the following two concentration-time profiles after a single bolus injection. The two lines differ in only one of the subsequent parameters (Vd, Dose, clearance). Please circle the parameter they differ in (6 points). 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 0 10 20 30 The 2 lines differ in Dose Vd Clearance 3

3. For the physiological changes listed below, select the induced changes on the pharmacokinetic parameters for a lipophilic, neutral (no acid or basic group in the molecule), protein bound, low extraction drug that is also eliminated by renal elimination (some answers may be used more than once). (15 points) Write your selection (a, b, c, d, e, f, or g) on the line behind the physiological change. Physiological change Induced changes on kinetic parameters 1.) Increase in metabolic enzymes a. ClREN 2.) Decrease in urine flow b. ClHEP 3.) Increase in liver blood flow c. oral bioavailability 4.) Decrease in number of fat cells d. VD 5.) Increase in plasma protein binding e. oral bioavailability F f. VD g. none of the above 4

4. For the following situations, indicate whether the drug is filtered, reabsorbed or actively secreted (Assume GFR is 130 ml min -1, urine flow is 1.5 ml min -1 ) (12 points) A drug with fu = 0.02and a ClREN = 20 ml min -1 is A drug with fu = 0.40 and a ClREN = 52 ml min -1 is A drug with fu = 0.30 and a ClREN = 0.45 ml min -1 is 5

5. A drug is eliminated through glomerular filtration and hepatic metabolism (no other clearance mechanisms are observed). The drug has a plasma protein binding of 50%. Glomerular filtration rate in the patient of interest is normal (130 ml/min). The drug is highly ionized, but not subject to active transport. The volume of distribution is 50 L. When given as an i.v. bolus, plasma concentrations two hour after administration were 5.2 mg/l. Four hours after administration the concentration was 2.6 mg/l. (25 pts) 5a. What is the ke? Provide full calculations and circle correct answer. Correct answer is only granted if you show calculations? Answer: Circle the correct answer 0.15 h -1 0.25 h -1 0.3 h -1 0.35 h -1 0.4 h -1 0.45 h -1 0.5 h -1 0.55 h -1 0.6h -1 0.65 h -1 0.7h -1 0.85 h -1 0.9 h -1 1 h -1 1.1 h -1 1.2 h -1 12h -1 120 h -1 6

5b. What is the total clearance of the drug. Provide full calculations and circle estimate closest to your answer from the list below. Correct answer is only granted if you show full calculations. Answer: 0.1L/h 0.2L/h 0.4 L/h 0.61L/h 0.8 L/h 1 L/h 3L/h 5L/h 7L/h 9 L/h 11L/h 13L/h 15 L/h 17L/h 21L/h 24L/h 27L/h 30L/h 33L/h 40L/h 45L/h 50L/h 55L/h 60L/h 65L/h 70L/h 80L/h 90L/h 100L/h 150L/h 7

5c. What is the renal clearance of the drug? Circle the answer closest to your estimate from the list below. Answer: Circle the correct answer 0.1 L/h 0.2 L/h 0.3 L/h 0.4 L/h 0.5 L/h 0.7 L/h 1L/h 2L/h 3 L/h 4 L/h 6L/h 9L/h 12L/h 15l/h 18L/h 21L/h 24L/h 27L/h 30L/h 33L/h 40L/h 45L/h 50L/h 55L/h 60L/h 65L/h 70L/h 80L/h 90L/h 100L/h 150L/h 8

5d. What is the hepatic clearance of the drug?? Circle the answer closest to your estimate from the list below. Answer: Circle the correct answer 0.1 L/h 0.2 L/h 0.3 L/h 0.4 L/h 0.5L/h 0.6L/h 0.7 L/h 0.8L/h 0.9L/h 1.0L/h 1.0 L/h 1.2 L/h 1.4 L/h 1.6 L/h 1.8L 2.0L/h 2.2 L/h 2.4L/h 2.8L/h 3.0L/h 3.1 L/h 3.3 L/h 3.5 L/h 3.7 L/h 3.9 L/h 4.1 L/h 4.3 L/h 4.5 L/h 4.7 L/h 5 L/h 7 L/h 9 L/h 10 L/h 12L/h 14L/h 18 L/h 22L/h 26 L/h 30L/h 40L/h 9

6. The same dose of Alprazolam was given either with placebo or with carbamazepine. Briefly Eexplain what is going on, in 5 words or less. (10 points) Please answer in not more than 2 words or less. 10

7.) Which of the following statements (there can be more than 1 false) about renal clearance is (are) false wrong? (10 points) A) The degree of tubular reabsorption might be affected by the ph of the urine. B) Highly ionized drugs with no affinity to transporters tend to stay in the urine. C) Tubular reabsorption can only be an active process. D) The renal clearance of serum creatinine is identical the GFR. E) Creatine clearance can only be used to estimate the renal clearance of drugs that are similar to creatine, which does do not show plasma albumin binding.. List wrong statement(s): 11

8.) Which of the following statements concerning volume of distribution is (are) correct? Consider that the amount of drug in the body is constant. (12 points) A) The higher the volume of distribution, the more drug is in the tissue. B) The lower the volume of distribution, the lower the drug concentration in plasma. C) The volume of distribution relates the amount of drug in the body to the plasma concentration. D) The volume of distribution relates the plasma concentration to the actual tissue concentration. E) The volume of distribution increases with increasing blood flow. F) For a lipophilic drug, a large volume of distribution can only be observed if the plasma protein binding is less than the tissue binding. List the correct statements: 12

9) What of the following statements concerning a drug distributed according to perfusion limitations are correct? Assume no active transport. (10 points) A) The drug can not be a strong acid. B) The drug can not be a strong base. C) The drug can be a weak base D) The drug can be a weak acid. E) Such a drug will generally enter tissues faster than a drug showing permeability limited uptake. Correct answer(s): 13

10) Patient 1 received a drug as an iv bolus injection. Pharmacokinetic and physiological characteristics, such as dose, fraction of the drug unbound in plasma and tissue, intrinsic clearance, liver blood flow, and volume of plasma and volume of the tissue water in this patient are shown below. (16 points) TABLE 1: INPUT PARAMETERS Patient 1 D [mg] 40 fu 1 fut 0.3 CLi [L/h] 3 Q [L/h] 90 Vp [L] 3 VTW [L] 38 The next table shows the resulting pharmacokinetic parameters in this ppatient 1. Let's assume a second patient will receives the same dose of this drug, given again as an iv bolus injection. Both patients differ only in the plasma protein binding to this drug. As you can see from the INPUT parameters, 100% of the drug in plasma is free for Patient 1. Contrary to this, in Patient 2, 33% of the drug present in plasma is free. Please mark in the free column of the Table 2 for each parameter whether the parameter (Peak concentration, Ke, V, Cl, t1/2, E, F, AUC ) will be the same ( ), will be larger ( ), or will be smaller ( ) than those estimates observed in Patient 1. Table 2: OUTPUT PARAMETERS Patient 1 Patient 2 Peak [ug/ml] 0.3 Ke [1/h] 0.02 V [L] 130 CL [L/h] 2.9 t1/2 [h] 31.0 E 0.03 F [%] 96.8 AUC [ug/ml*h] 13.8 14